Bao Y - Search Results

1

Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial.

Lu S, Wang J, Yu Y, Yu X, Hu Y, Ai X, Ma Z, Li X, Zhuang W, Liu Y, Li W, Cui J, Wang D, Liao W, Zhou J, Wang Z, Sun Y, Qiu X, Gao J, Bao Y, Liang L, Wang M. Lu S, et al. Among authors: bao y. J Thorac Oncol. 2021 Sep;16(9):1512-1522. doi: 10.1016/j.jtho.2021.05.005. Epub 2021 May 23. J Thorac Oncol. 2021. PMID: 34033975 Free article. Clinical Trial.

2

Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non-Small Cell Lung Cancer.

Lu S, Yu Y, Barnes G, Qiu X, Bao Y, Tang B. Lu S, et al. Among authors: bao y. Cancer J. 2022 Mar-Apr 01;28(2):96-104. doi: 10.1097/PPO.0000000000000583. Cancer J. 2022. PMID: 35333492 Free PMC article. Clinical Trial.

3

Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma.

Ye D, Liu J, Zhou A, Zou Q, Li H, Fu C, Hu H, Huang J, Zhu S, Jin J, Ma L, Guo J, Xiao J, Park SH, Zhang D, Qiu X, Bao Y, Zhang L, Shen W, Bi F. Ye D, et al. Among authors: bao y. Cancer Sci. 2021 Jan;112(1):305-313. doi: 10.1111/cas.14681. Epub 2020 Nov 6. Cancer Sci. 2021. PMID: 33047430 Free PMC article. Clinical Trial.

4

Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection.

Tang ZY, Liu KD, Bao YM, Lu JZ, Yu YQ, Ma ZC, Zhou XD, Yang R, Gan YH, Lin ZY, et al. Tang ZY, et al. Among authors: bao ym. Cancer. 1990 Jan 15;65(2):211-5. doi: 10.1002/1097-0142(19900115)65:2<211::aid-cncr2820650205>3.0.co;2-g. Cancer. 1990. PMID: 1688507

5

Hepatic artery ligation and infusion chemotherapy for unresectable primary liver cancer.

Zhou XD, Tang ZY, Yu YQ, Ma ZC, Xu DB, Bao YM, Yang R, Zhang M, Zhou M. Zhou XD, et al. Among authors: bao ym. Chin Med J (Engl). 1991 Oct;104(10):846-50. Chin Med J (Engl). 1991. PMID: 1661226

6

High expression of human clotting factor IX cDNA in myoblasts C2C12 cells and C3H mice.

Wang H, Bao Y, Lu D, Qiu X, Xue J. Wang H, et al. Among authors: bao y. Sci China C Life Sci. 1997 Aug;40(4):371-8. doi: 10.1007/BF02881730. Sci China C Life Sci. 1997. PMID: 18762876

7

[Determination of the polymorphism of DXS102 locus and its application in gene diagnosis].

Bao Y, Lu D, Shi Q, Xu H, Qiu X, Xue J. Bao Y, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 1998 Feb 10;15(1):27-30. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 1998. PMID: 9456368 Chinese.

8

Polymorphism of DXS102 locus in Chinese population and its application to gene diagnosis in hemophilia B family.

Bao Y, Lu D, Xu H, Shi Q, Qiu X, Xue J. Bao Y, et al. Chin Med J (Engl). 1998 Jun;111(6):527-30. Chin Med J (Engl). 1998. PMID: 11245073

9

[Radioimmunotherapy combined with chemotherapy and immunotherapy for nude mice bearing human hepatocellular carcinoma].

Bao YM. Bao YM. Zhonghua Zhong Liu Za Zhi. 1989 Jul;11(4):245-7. Zhonghua Zhong Liu Za Zhi. 1989. PMID: 2625102 Chinese.

10

[Radiotherapy alternated with chemotherapy and immunotherapy on nude mice bearing human hepatocellular carcinoma].

Bao YM. Bao YM. Zhonghua Zhong Liu Za Zhi. 1988 Sep;10(5):382-4. Zhonghua Zhong Liu Za Zhi. 1988. PMID: 2470566 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,091 results

Search Page

Filters